The week in health tech, explained in plain English.Get the free newsletter →
October 15, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

Why New CTE Data on Football Shouldn't Shock Anyone

The latest research on chronic traumatic encephalopathy (CTE) in football players puts hard numbers on a danger that has been documented for decades. Writing in STAT News, historian Emily Harrison, who studies brain injury in football, argues that the newest Boston University statistics "quantify but do not reveal a problem." The real story, she says, is why society keeps treating each finding as a surprise.

CTE, a degenerative brain disease tied to repeated head impacts, has been linked to football through years of Boston University research on deceased players. Each new dataset tends to generate fresh alarm, then fade without structural change to how the sport is played or how young athletes are protected.

Harrison's point is a challenge to clinicians, sports organizations, and policymakers: the evidence base is mature, and continued shock functions as a substitute for action. Understanding CTE as a known, measurable risk, rather than an emerging mystery, is the precondition for meaningful prevention and policy response.

Sources

More in Government

Government

Pennsylvania Sues Insulin Makers and PBMs Over Pricing

Pennsylvania's attorney general sued three insulin makers and several PBMs, alleging they colluded to manipulate insulin prices and raise patient costs.

Why it matters: The case adds to mounting legal pressure on insulin pricing and PBM rebate practices that determine what diabetic patients pay at the pharmacy.

Government

CMS Shaped AI Health Policy in a Private Slack

A KFF Health News investigation found CMS used a 1,700-member Slack of tech executives and investors to help shape federal AI healthcare policy outside public channels.

Why it matters: Federal AI rules will govern how healthcare algorithms are paid for and deployed, so who gets private access to shape them affects the entire industry.

Government

NIH Plans National Push on Personalized Cancer Vaccines

The NIH plans a December public-private partnership to accelerate development of personalized cancer vaccines, per a New York Times report.

Why it matters: A federally coordinated effort could accelerate a promising but fragmented field of custom cancer immunotherapies toward wider clinical use.